Open date: December 20, 2022
Most recent review date: Tuesday, Aug 29, 2023 at 11:59pm (Pacific Time)
Applications received after this date will be reviewed by the search committee if the position has not yet been filled.
Final date: Monday, Oct 30, 2023 at 11:59pm (Pacific Time)
Applications will continue to be accepted until this date, but those received after the review date will only be considered if the position has not yet been filled.
The University of California Irvine (UCI) Sue & Bill Gross Stem Cell Research Center (SCRC; www.stemcell.uci.edu) and School of Medicine (SOM, https://www.som.uci.edu) invite applications from outstanding candidates for a tenure-track/tenured faculty position (open rank) as Associate Director for Cell and Gene Therapy. The goals of this position are to enhance: investigator-initiated clinical trials for FDA regulated cell & biotechnologies; access of UCI Health clients to public-private partnership initiated FDA regulated clinical trials for cell technologies aligned with institutional strengths; advanced biotherapeutics and clinical services operations in alignment with the UCI Health mission; and, work force development to support translational advances in cell and gene therapy / regenerative medicine. This position will report to the SCRC Director, with parallel reporting to the Cell and Gene Therapy oversight committee, and be responsible for the Medical Directorship and operations of the GMP facility.
This academic appointment is open to MD or MD/PhD scientists, and will be made at the Assistant, Associate, or Full Professor level in an appropriate SOM department; start-up package commensurate with appointment level. DO and MBSS candidates will also be considered. Candidates will be expected to bring a robust extramurally funded research program with a clinical translation focus in cell and gene therapy / regenerative medicine. Successful candidates will have significant expertise in clinical pathway development, IND submission and regulatory processes, and GMP cell manufacturing, as well as the development of academic-industry partnerships. The candidate’s areas of research interest should complement translational foci in the SOM and College of Health Sciences (COHS), including but not limited to autologous and allogeneic cellular therapies for cancer and neurological disease. In keeping with the commitment of UCI to inclusive excellence, applicants must provide a statement that addresses past and/or potential contributions to diversity, equity and inclusion.
UCI SOM/COHS programs include strong resources across multiple translational themes, including the SCRC (www.stemcell.uci.edu) and California Institute of Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC; https://clinic.stemcell.uci.edu); Institute for Clinical and Translational Science (http://www.icts.uci.edu); Chao Family Comprehensive Cancer Center (http://www.cancer.uci.edu); Cancer Research Institute (http://cri.bio.uci.edu (http://cri.bio.uci.edu); and, Institute for Immunology (http://www.immunology.uci.edu).
Interested individuals should apply online through UCI RECRUIT at: https://recruit.ap.uci.edu/JPF08021
Application materials required: 1) Cover letter; 2) Curriculum vitae; 3) Summary of research interests (up to 3 pages); 4) Summary of teaching philosophy (1 page); 5) Names and contact information for 3-5 individuals who can provide a letter of reference upon request; 6) Statement of Contributions to Diversity; 7) Completed Authorization to Release Information Form; 8) PDFs of 3-5 recent publications.
Institutional Reference Check:
The University of California is committed to creating and maintaining a community dedicated to the advancement, application, and transmission of knowledge and creative endeavors through academic excellence; where all individuals who participate in University programs and activities can work and learn together in a safe and secure environment, free of violence, harassment, discrimination, exploitation, or intimidation. In support of this commitment, and as a means to address all forms of academic misconduct, UC Irvine will conduct an institutional reference check on recruitment finalists of Senate Ladder-Rank Professor and Professor of Teaching series, at all ranks (i.e. assistant, associate, full), prior to extending a formal offer of appointment. Applications submitted via AP Recruit must include a signed copy of the Authorization to Release Information Form for consideration.
Applications should be submitted prior to May 31, 2023.
Inquiries about the position should be directed to the Grant Cooper Team: Rachel Charney, firstname.lastname@example.org
MD or MD/PhD degree, postdoctoral experience, and active research program in stem cell biology and regenerative medicine.
Curriculum Vitae - Your most recently updated C.V.
Statement of Research
Teaching Statement - See our guidance for writing a reflective teaching statement.
Inclusive Excellence Activities Statement - Statement addressing how past and/or potential contributions to inclusive excellence will advance UCI's Commitment to Inclusive Excellence. See our guidance for writing an inclusive excellence activities statement.
Authorization to Release Information Form - A reference check will be completed only if you are made a tentative offer to a Professor or Professor of Teaching series, at any rank. Download, complete, sign, and upload the form: https://ap.uci.edu/files/2020/07/AuthReleaseForm.pdf
Misc / Additional - PDF version of 3-5 relevant publications
- 3-5 required (contact information only)
The University of California, Irvine is an Equal Opportunity/Affirmative Action Employer advancing inclusive excellence. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC nondiscrimination policy.
As a University employee, you will be required to comply with all applicable University policies and/or collective bargaining agreements, as may be amended from time to time. Federal, state, or local government directives may impose additional requirements.